Rick E. Winningham - Feb 28, 2025 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Stock symbol
TBPH
Transactions as of
Feb 28, 2025
Transactions value $
$20,364
Form type
4
Date filed
3/4/2025, 06:17 PM
Previous filing
Feb 24, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Award $20.4K +2.18K +0.12% $9.35 1.78M Feb 28, 2025 Direct F1
holding TBPH Ordinary Shares 3.9K Feb 28, 2025 As Custodian
holding TBPH Ordinary Shares 92.6K Feb 28, 2025 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an acquisition from the Issuer pursuant to a restricted share purchase agreement under the Issuer's Amended and Restated 2013 Equity Incentive Plan at a per-share price equal to the closing per-share price of the Issuer's ordinary shares on the Nasdaq Global Market on February 28, 2025.